PerspectiveImmunology

The Shape of Things to Come

Science  15 Jun 2007:
Vol. 316, Issue 5831, pp. 1574-1576
DOI: 10.1126/science.1144483

You are currently viewing the summary.

View Full Text

Summary

Mechanistic understanding of how ligands can fine-tune the immune response may lead to better vaccine adjuvants.